REFERENCES
- Carretero O A, Oparil S. Essential hypertension. Part I: Definition and etiology. Circulation. 2000; 101: 329–335
- Kearney P, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: A systematic review. J Hypertens. 2004; 22: 11–19
- Quigley H A, Broman A T. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90: 262–267
- Leighton D A, Phillips C I. Systemic blood pressure in open-angle glaucoma, low-tension glaucoma, and the normal eye. Br J Ophthalmol 1972; 56: 447–453
- Tielsch J M, Katz J, Sommer A, et al. Hypertension, perfusion pressure, and primary open angle glaucoma. A population-based assessment. Arch Ophthalmol. 1995; 113: 216–221
- Bonomi L, Marchini G, Marraffa M, et al. Vascular risk factors for primary open angle glaucoma: The Egna-Neumarkt Study. Ophthalmology. 2000; 107: 1287–1293
- Dielemans I, Vingerling J R, Algra D, et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: The Rotterdam Study. Ophthalmology 1995; 102: 54–60
- Klein B E, Klein R, Knudtson M D. Intraocular pressure and systemic blood pressure: Longitudinal perspective: The Beaver Dam Eye Study. Br J Ophthalmol. 2005; 89: 284–287
- Mitchell P, Lee A J, Rochtcina E, Wang J J. Open-angle glaucoma and systemic hypertension: The Blue Mountains Eye Study. J Glaucoma. 2004; 13: 319–326
- Leske M C, Connell A M, Wu S Y, et al. Risk factors for open angle glaucoma: The Barbados Eye Study. Arch Ophthalmol 1995; 113: 918–924
- Sommer A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr Opin Ophthalmol. 1996; 7: 93–98
- Kontiola A I, Goldblum D, Mittag T, Danias J. The induction/impact tonometer: A new instrument to measure intraocular pressure in the rat. Exp Eye Res. 2001; 73: 781–785
- Wang W H, Millar J C, Pang I H, et al. Noninvasive measurement of rodent intraocular pressure with a rebound tonometer. Invest Ophthalmol Vis Sci. 2005; 46: 4617–4621
- Goldblum D, Kontiola A I, Mittag T, et al. Non-invasive determination of intraocular pressure in the rat eye. Comparison of an electronic tonometer (Tono-Pen) and a rebound (impact probe) tonometer. Graef Arch Clin Exp Ophthalmol. 2002; 240: 942–946
- Pease M E, Hammond J C, Quigley H A. Manometric calibration and comparison of TonoLab and Tono-Pen tonometers in rats with experimental glaucoma and in normal mice. J Glaucoma. 2006; 15: 512–519
- Louhelainen M, Merasto S, Finckenberg P, et al. Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. J Hypertens 2006; 24: 947–956
- Mervaala E, Müller D N, Schmidt F, et al. Blood pressure independent effects in rats with human renin and angiotensinogen genes. Hypertension 2000; 35: 587–594
- Pilvi T K, Jauhiainen T, Cheng Z J, et al. Lupin protein attenuates the development of hypertension and normalizes the vascular function of NaCl-loaded Goto-Kakizaki rats. J Physiol Pharmacol 2006; 57: 167–176
- StataCorp. Stata Statistical Software: Release 10. StataCorp LP, College Station, TX 2007
- Liu J H, Kripke D F, Hoffman R E, et al. Nocturnal elevation of IOP in young adults. Invest Ophthalmol Vis Sci. 1998; 39: 2707–2712
- Liu J H, Kripke D F, Hoffman R E, et al. Twenty-four-hour pattern of intraocular pressure in the aging population. Invest Ophthalmol Vis Sci. 1999; 40: 2912–2917
- Krishna R, Mermoud A, Baerveldt G, Minckler D S. Circadian rhythm of intraocular pressure: A rat model. Ophthalmic Res 1995; 27: 163–167
- Sugimoto E, Aihara M, Ota T, Araie M. Effect of light cycle on 24-hour pattern of mouse intraocular pressure. J Glaucoma 2006; 15: 505–511
- Moore C G, Johnson E C, Morrison J C. Circadian rhythm of intraocular pressure in the rat. Curr Eye Res. 1996; 15: 185–191
- Mermoud A, Baerveldt G, Minckler D S, et al. Intraocular pressure in Lewis rats. Invest Ophthalmol Vis Sci 1994; 35: 2455–2460
- Xu L, Wang H, Wang Y, Jonas J B. Intraocular pressure correlated with arterial blood pressure: The Beijing Eye Study. Am J Ophthalmol 2007; 144: 461–462
- Gherghel D, Hosking S L, Orgül S. Autonomic nervous system, circadian rhythms, and primary open-angle glaucoma. Surv Ophthalmol 2004; 49: 491–508
- Costagliola C, Verolino M, de Rosa M L, et al. Effect of oral losartan potassium on intraocular pressure in normotensive and glaucomatous human subjects. Exp Eye Res 2000; 71: 167–171
- Costagliola C, Di Benedetto R, De Caprio L, et al. Effect of oral captopril (SQ 14225) on intraocular pressure in man. Eur J Ophthalmol 1995; 5: 19–25
- Watkins R W, Baum T, Cedeno K, et al. Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits. J Ocul Pharmacol 1987; 3: 295–307
- Vogh B P, Godman D R. Effects of inhibition of angiotensin converting enzyme and carbonic anhydrase on fluid production by ciliary process, choroid plexus, and pancreas. J Ocul Pharmacol 1989; 5: 303–311
- Wang R F, Podos S M, Mittag T W, Yokoyoma T. Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes. Exp Eye Res 2005; 80: 629–632
- Inoue T, Yokoyoma T, Mori Y, et al. The effect of topical CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure and aqueous humor dynamics in rabbits. Curr Eye Res 2001; 23: 133–138
- Shah G B, Sharma S, Mehta A A, Goyal R K. Oculohypotensive effect of angiotensin-converting enzyme inhibitors in acute and chronic models of glaucoma. J Cardiovasc Pharmacol 2000; 36: 169–175
- Constad W H, Fiore P, Samson C, Cinotti A A. Use of an angiotensin-converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol. 1988; 105: 674–677
- Danser A HJ, Derkx F HM, Admiraal P JJ, et al. Angiotensin levels in the eye. Invest Ophthalmol Vis Sci 1994; 35: 1008–1018
- Sramek S J, Wallow I HL, Tewksbury D A, et al. An ocular renin-angiotensin system. Immunohistochemistry of angiotensinogen. Invest Ophthalmol Vis Sci. 1992; 33: 1627–1632
- Wagner J, Danser J AH, Derkx F H, et al. Demonstration of renin mRNA, angiotensinogen mRNA, and angiotensin-converting enzyme mRNA expression in the human eye: Evidence for an intraocular renin-angiotensin system. Br J Ophthalmol. 1996; 0: 159–163
- Savaskan E, Loffler K U, Meier F, et al. Immunohistochemical localization of angiotensin-converting enzyme, angiotensin II, and AT1 receptor in human ocular tissues. Ophthalmic Res 2004; 36: 312–320
- Hoy Y, Delamere N A. Influence of ANG II on cytoplasmic sodium in cultured rabbit nonpigmented ciliary epithelium. Am J Physiol Cell Physiol 2002; 283: 552–559
- Vaajanen A, Vapaatalo H, Kautiainen H, Oksala O. Angiotensin (1-7) reduces intraocular pressure in the normotensive rabbit eye. Invest Ophthalmol Vis Sci 2008, in press